MAT Waiver Training Initiative
PAEA is partnering with the American Academy of Addiction Psychiatry and a coalition of national professional organizations in a grant funded by SAMHSA called State Targeted Response-Technical Assistance (STR-TA). PAEA as a partner organization will focus on assisting PA programs with incorporating medication-assisted treatment (MAT) waiver training into their curricula. PAEA’s vision is that all PA program graduates and faculty will be waiver eligible.
What is MAT?
MAT is the use of medications to treat persons with opiate use disorder. The three medications approved by the FDA for MAT are methadone, buprenorphine, and naltrexone.
Funding for this grant from the Substance Abuse and Mental Health Services Administration will help us assist programs with incorporating MAT training into PA programs’ curricula.
NIDA. (2016, November 1). Effective Treatments for Opioid Addiction. Retrieved on June 25, 2018
Frequently Asked Questions
Read through the FAQs for more information on training and implementing MAT training into PA programs.
- PAs can apply for the DEA X-waiver to prescribe buprenorphine for MAT of opioid use disorder following completion of 24 hours of training by an approved organization.
- MAT waiver training is provided by these DATA 2000 approved sponsors:
- The American Academy of Physician Assistants approved MAT waiver training for 24 hours of category I CME credits.
NPI as a Unique Identifier
MAT Initiative Information Session and Q&A
This webinar presents an overview of PAEA’s Medication-Assisted Treatment waiver training initiative and will go over MAT training resources.
SAMHSA Grants for MAT Training Awarded to Five PA Programs – October 17, 2018
PAEA Welcomes MAT Initiative Director John Lopes – June 13, 2018
Video Introduces Valuable MAT Initiative – May 30, 2018
Resources on Training
Click on each category header to view relevant links.